BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30763649)

  • 1. The impact of environmental ultraviolet exposure on the clinical course of mycosis fungoides.
    DeStefano CB; Desale S; Fernandez SJ; Shenoy AG
    J Am Acad Dermatol; 2019 Nov; 81(5):1074-1077. PubMed ID: 30763649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
    Phan K; Ramachandran V; Fassihi H; Sebaratnam DF
    JAMA Dermatol; 2019 Mar; 155(3):335-341. PubMed ID: 30698622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure.
    Richards TB; Johnson CJ; Tatalovich Z; Cockburn M; Eide MJ; Henry KA; Lai SM; Cherala SS; Huang Y; Ajani UA
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S50-7. PubMed ID: 22018067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phototherapy of Mycosis Fungoides.
    Hodak E; Pavlovsky L
    Dermatol Clin; 2015 Oct; 33(4):697-702. PubMed ID: 26433842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Cutaneous T-Cell Lymphoma Caused by Ultraviolet Radiation? A Comparison of UV Mutational Signatures in Malignant Melanoma and Mycosis Fungoides.
    Gniadecki R; O'Keefe S; Hennessey D; Iyer A
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides.
    Hofer A; Cerroni L; Kerl H; Wolf P
    Arch Dermatol; 1999 Nov; 135(11):1377-80. PubMed ID: 10566837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
    Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental risk factors for mycosis fungoides.
    Wohl Y; Tur E
    Curr Probl Dermatol; 2007; 35():52-64. PubMed ID: 17641490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides.
    Väkevä L; Sarna S; Vaalasti A; Pukkala E; Kariniemi AL; Ranki A
    Acta Derm Venereol; 2005; 85(4):318-23. PubMed ID: 16191852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
    Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet A1 Phototherapy in the Treatment of Early Mycosis Fungoides.
    Adışen E; Tektaş V; Erduran F; Erdem Ö; Gürer MA
    Dermatology; 2017; 233(2-3):192-198. PubMed ID: 28441652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma.
    Schmidt AN; Robbins JB; Greer JP; Zic JA
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S202-5. PubMed ID: 16631940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do environmental factors play any role in the pathogenesis of mycosis fungoides and Sézary syndrome?
    Teixeira F; Ortiz-Plata A; Cortes-Franco R; Domínguez-Soto L
    Int J Dermatol; 1994 Nov; 33(11):770-2. PubMed ID: 7822078
    [No Abstract]   [Full Text] [Related]  

  • 14. Phototherapy for mycosis fungoides.
    Dogra S; Mahajan R
    Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
    Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
    J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
    Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
    J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States.
    Xia FD; Ferket BS; Huang V; Stern RS; Wu PA
    J Am Acad Dermatol; 2019 Feb; 80(2):485-492.e4. PubMed ID: 30081119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides.
    Xiao T; Xia LX; Yang ZH; He CD; Gao XH; Chen HD
    Eur J Dermatol; 2008; 18(6):660-2. PubMed ID: 18955199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides: review of epidemiological observations.
    Morales Suárez-Varela MM; Llopis González A; Marquina Vila A; Bell J
    Dermatology; 2000; 201(1):21-8. PubMed ID: 10971054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.